Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and a Favorable Safety Profile

Click here to view

Presentation

Poster: Unraveling Impact of Manufacturing Process-Related Stresses on AAV Stability, Aggregation, and DNA Release

Download PDF